Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de William Mezzanotte
Country of residence : Unknown
Linked companies : CSL Limited - BELLUS Health Inc.

Biography of William Mezzanotte 
Currently, William Mezzanotte is Chief Medical Officer, EVP & Head-R&D at CSL Ltd. Dr. Mezzanotte is also on the board of BELLUS Health, Inc. and University City Science Center. Dr. Mezzanotte previously was Vice President & Head-Respiratory & Inflammation at AstraZeneca Plc and Senior Vice President & Head-Therapeutic Area at C.H. Boehringer Sohn AG & Co. KG. William Mezzanotte received an undergraduate degree from Villanova University, a doctorate from the University of Pennsylvania and a graduate degree from The Johns Hopkins University.


Current positions of William Mezzanotte 
Holdings of William Mezzanotte 
William Mezzanotte : Personal Network 
Most Read News 
05/11CATHIE WOOD : Tumble in Coinbase pushes Wood's ARK fund closer to pandemic low
RE
05/20XAVIER NIEL : UWR shares spike as billionaire Xavier Niel discloses 27% stake
RE
05/12MASAYOSHI SON : SoftBank Vision Fund posts $26 billion loss; Son pledges defence
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/24ELON MUSK : In a faceoff with Elon Musk, the SEC blinked
RE
05/11ELON MUSK : Musk's delay in disclosing Twitter stake triggers SEC probe - WSJ
RE
05/19ELON MUSK : Musk says 'Tesla is on my mind 24/7' amid concerns about Twitter distraction
RE
05/17ELON MUSK : Prominent hedge funds invested in Twitter before Musk unveiled plans
RE
05/25ELON MUSK : Twitter investors vote against re-electing Elon Musk ally to board
RE
05/23HOCK TAN : Chipmaker Broadcom in talks to acquire VMware for $60 billion -sources
RE
More news


© 2022 People and Ownership :   
William Mezzanotte : Connections 


Latest news about William Mezzanotte 
05/11TRANSCRIPT : BELLUS Health Inc. - Shareholder/Analyst Call
CI
2021TRANSCRIPT : BELLUS Health Inc. - Shareholder/Analyst Call
CI
2021BELLUS Health Appoints William Mezzanotte to Its Board of Directors
CI
2017TRANSCRIPT : CSL Limited - Special Call
CI
2014TRANSCRIPT : AstraZeneca PLC - Shareholder/Analyst Call
CI
More news